Article
Factor VIII haplotypes frequencies in Tunisian hemophiliacs A.
Diagnostic pathology - 17 Jun 2011
Elmahmoudi Hejer, Belhedi Nejla, Jlizi Asma, Zahra Kaouther, Meddeb Balkis, Ben Ammar Elgaaied Amel, Gouider Emna
Abstract excerpt
BACKGROUND: The development of inhibitors against factor 8 (F8) is the most serious complication of replacement therapy with F8 in children with severe hemophilia. It was suggested that mismatched F8 replacement therapy may be a risk factor for the development of anti-factor F8 alloantibodies. Recently four single nucleotide polymorphisms (SNPs) encoding six distinct haplotypes, designated H1 through H6, were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
